TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TRVI

Trevi Therapeutics Inc

Healthcare · Biotechnology

15.00$ -1.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Trevi Therapeutics Inc (TRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 193 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRVI
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
8.4 22 20 60 47 38 123 89 111 193
8.4 22 19 60 46 38 123 88 109 192
8.3 22 17 57 45 37 13 32 34 19
8.3 22 17 57 45 37 121 83 108 188
0.0 0.1 0.2 0.6 0.3 0.2 0.5 1.0
0.0 0.1 1.4 1.6 0.9 -0.2
0.0 0.0 0.1 0.4 0.3 0.2 0.2
0.0 0.0 0.0
0.0 0.0 0.0
26 7.5 3.2 5.5 20 21 16 6.9 11 10
20 7.1 2.7 5.2 5.6 13 13 5.8 11 9.7
17 5.3 0.0 0.1 0.1 6.0 7.0 0.3 0.3 0.3
0.4 0.5 0.6 1.6 2.0 2.8 2.9 1.8 3.4 3.9
5.1 0.0 1.1 14 8.7 2.2
-17 15 17 55 27 17 107 83 100 183
-72 -84 -109 -114 -147 -181 -210 -239 -287 -330
16 9.0 9.0 18 18 23 65 99 101 145

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?